Real-time Artificial Intelligence System for Detecting Multiple Ocular Fundus Lesions by Ultra-widefield Fundus Imaging
NCT ID: NCT04859634
Last Updated: 2021-04-26
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
UNKNOWN
2000 participants
OBSERVATIONAL
2020-11-01
2022-12-25
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
AI Classifies Multi-Retinal Diseases
NCT04592068
Artificial Intelligence System for Assessing Image Quality of Fundus Images and Its Effects on Diagnosis
NCT04289064
Development and Validation of a Deep Learning System for Multiple Ocular Fundus Diseases Using Retinal Images
NCT04213430
Real-world of AI in Diagnosing Retinal Diseases
NCT05981950
Multi-modal Imaging and Artificial Intelligence Diagnostic System for Multi-level Clinical Application
NCT03899623
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
This study will develop an artificial intelligence system integrating with ultra-widefield fundus imaging to automatically screen for multiple ocular fundus lesions in real time and evaluate its performance in different real-world settings. The efficacy of the system will compare to the final diagnoses of each participant made by experienced ophthalmologists.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Beijin Tongren Hospital
The participant only needs to take an ultra-widefield fundus image as usual.
Taking an ultra-widefield fundus image
The participant only needs to take an ultra-widefield fundus image as usual.
Zhongshan Ophthalmic Center
The participant only needs to take an ultra-widefield fundus image as usual.
Taking an ultra-widefield fundus image
The participant only needs to take an ultra-widefield fundus image as usual.
Shenzhen Ophthalmic Center
The participant only needs to take an ultra-widefield fundus image as usual.
Taking an ultra-widefield fundus image
The participant only needs to take an ultra-widefield fundus image as usual.
Xudong Ophthalmic Center
The participant only needs to take an ultra-widefield fundus image as usual.
Taking an ultra-widefield fundus image
The participant only needs to take an ultra-widefield fundus image as usual.
IKang Physical Examination Center
The participant only needs to take an ultra-widefield fundus image as usual.
Taking an ultra-widefield fundus image
The participant only needs to take an ultra-widefield fundus image as usual.
Yangxi General Hospital People's Hospital
The participant only needs to take an ultra-widefield fundus image as usual.
Taking an ultra-widefield fundus image
The participant only needs to take an ultra-widefield fundus image as usual.
Guangdong Provincial People's Hospital
The participant only needs to take an ultra-widefield fundus image as usual.
Taking an ultra-widefield fundus image
The participant only needs to take an ultra-widefield fundus image as usual.
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Taking an ultra-widefield fundus image
The participant only needs to take an ultra-widefield fundus image as usual.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
2. Patients who do not agree to sign informed consent.
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Shenzhen Eye Hospital
OTHER
Xudong Ophthalmic Hospital
UNKNOWN
IKang Physical Examination Center
UNKNOWN
Beijing Tongren Hospital
OTHER
Guangdong Provincial People's Hospital
OTHER
Yangxi General Hospital People's Hospital
UNKNOWN
Sun Yat-sen University
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Haotian Lin
Professor
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Zhongshan Ophthalmic Center, Sun Yat-sen University
Guangzhou, Guangdong, China
Countries
Review the countries where the study has at least one active or historical site.
Central Contacts
Reach out to these primary contacts for questions about participation or study logistics.
Facility Contacts
Find local site contact details for specific facilities participating in the trial.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
UWFAIDS2019-China-06
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.